Authors/Disclosures
Anastasie M. Dunn-Pirio, MD
(UC San Diego)
|
Dr. Dunn-Pirio has nothing to disclose. |
Katherine B. Peters, MD, PhD, FAAN
(Duke University Medical Center)
|
Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals. The institution of Dr. Peters has received research support from Nuvation. |
Ulas Celik
|
No disclosure on file |
Ricky Lee, MD
|
No disclosure on file |
Annick DesJardins, MD
(Duke University Medical Center)
|
Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biodexa. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chimerix. Dr. DesJardins has stock in Istari Oncology. Dr. DesJardins has received intellectual property interests from a discovery or technology relating to health care. |
Dina Randazzo, DO
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |